Table 2.
Characteristics of the study subgroups
| CKD 1–4 | Kidney transplantation (CKDT) | Hemodialysis (HD) | Peritoneal dialysis (PD) | |
|---|---|---|---|---|
| Age (years) | ||||
| Average* ± SD | 57.2 ± 19.4 | 50.1 ± 13.6 | 61.3 ± 11.1 | 55.9 ± 14.5 |
| Gender M/F | 292/282 | 178/136 | 17/23 | 21/23 |
| BMI (kg/m2) | ||||
| Average ± SD | 26.8 ± 5.4 | 25.6 ± 4.1 | 24.1 ± 3.8 | 26.1 ± 4.4 |
| Duration of CKD from diagnosis (years) | ||||
| Median and IQR | 7.0; 3.0–15.0 | 15.0; 10.0–22.0 | 14.0; 7.0–28.0 | 5.0; 3.0-14.5 |
| Bone-joint disease, n (%)** | 153 (27.5) | 42 (13.4) | 21 (52.5) | 2 (4.5) |
| Cancer, n (%)** | 60 (10.4) | 13 (4.1) | 1 (2.5) | 4 (9.1) |
| Diabetes, n (%)** | 135 (23.5) | 70 (22.3) | 10 (25.0) | 11 (25.0) |
| Hypertension, n (%)** | 432 (75.1) | 267 (85.0) | 30 (75.0) | 40 (91.0) |
| Cardiovascular disease, n (%)** | 175 (30.5) | 59 (18.8) | 18 (45.0) | 14 (31.8) |
IQR interquartile range, CKD chronic kidney disease
*ANOVA p < 0.001 (difference between study subgroups: CKD 1–4 vs. CKDT vs. HD vs. PD)
**χ2 test p < 0.001 (difference between study subgroups: CKD 1–4 vs. CKDT vs. HD vs. PD)